|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Avanir_Pharmaceuticals
gptkb:TetraLogic_Pharmaceuticals
|
|
gptkbp:awards
|
Best Places to Work
Top 100 Pharmaceutical Companies
Innovative_Company_Award
Corporate_Social_Responsibility_Award
|
|
gptkbp:clinicalTrials
|
ongoing
|
|
gptkbp:communityEngagement
|
educational programs
research grants
healthcare_initiatives
|
|
gptkbp:employees
|
approximately 1,000
|
|
gptkbp:focus
|
research and development
|
|
gptkbp:founded
|
1986
|
|
gptkbp:headCoach
|
gptkb:Mr._John_D._Doe
Dr. Thomas A. McGowan
|
|
gptkbp:headOfMarketing
|
gptkb:Ms._Jennifer_L._Smith
|
|
gptkbp:headquarters
|
gptkb:Princeton,_New_Jersey
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Otsuka America Pharmaceutical, Inc.
|
|
gptkbp:parentCompany
|
gptkb:Otsuka_Pharmaceutical_Co.,_Ltd.
|
|
gptkbp:partnerships
|
gptkb:Mitsubishi_Tanabe_Pharma_Corporation
gptkb:Bristol-Myers_Squibb
gptkb:Helsinn_Healthcare
|
|
gptkbp:philanthropy
|
gptkb:Otsuka_America_Pharmaceutical_Foundation
|
|
gptkbp:products
|
pharmaceuticals
|
|
gptkbp:regulatoryCompliance
|
gptkb:FDA
EMA
|
|
gptkbp:researchFocus
|
metabolic disorders
infectious diseases
neuropsychiatric disorders
|
|
gptkbp:specializesIn
|
oncology
central nervous system disorders
cardiovascular diseases
|
|
gptkbp:subsidiary
|
gptkb:Otsuka_Europe_Ltd.
gptkb:Otsuka_Canada_Pharmaceutical_Inc.
gptkb:Otsuka_Pharmaceutical_Co.,_Ltd.
gptkb:Otsuka_America,_Inc.
Otsuka_Pharmaceutical_Co.,_Ltd._(Japan)
|
|
gptkbp:sustainabilityInitiatives
|
energy efficiency
waste reduction
water conservation
environmental responsibility
|
|
gptkbp:website
|
www.otsuka-us.com
|